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Abstract
Background: Many anesthetic drugs interact with the NMDA receptor and may therefore alter the clinical
presentation of anti-NMDA-R encephalitis.
Case presentation: A 24-year-old woman was admitted to hospital for decreased consciousness and hyperthermia.
Cerebrospinal fluid analysis revealed lymphocytic pleocytosis, and elevated protein. Cultures were negative. Patient
state worsened with agitation, facial dyskinesia, ocular deviation, and limb dystonia. Diagnosis of anti-NMDA-R
encephalitis was evidenced by specific antibodies. High doses of methylprednisolone were administered. CT scan
disclosed an ovarian teratoma and tumor resection was scheduled under anesthesia with propofol, sufentanil,
atracurium and sevoflurane. Sedation after surgery was maintained with propofol. Rapidly after surgery, patient’s
condition deteriorated with increase of dyskinesias, and two tonic-clonic generalized seizure events.
Conclusion: In patients with anti-NMDA-R encephalitis, anesthesia using benzodiazepines, opiates and curares,
which fail to interfere with the NMDA pathway, should be preferred.
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Background
Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) en-
cephalitis has become the second most frequent cause
of immune-mediated encephalitis and probably remains
underdiagnosed. Its pathogenesis is based on NMDA
receptor blockade by patient’s auto-antibodies [1]. Many
anesthetic drugs interact with the NMDA receptor and
may therefore alter the clinical presentation of anti-
NMDA-R encephalitis [2]. We herein describe a patient
with documented anti-NMDA-R encephalitis whose symp-
toms dramatically worsened after a general anesthesia.
Case presentation
A 24-year-old woman with no medical history was admitted
to the hospital for decreased consciousness and hyperther-
mia. Two months earlier, her relatives noticed behavioral
changes with marked anxiety and depressive mood.
Cerebrospinal fluid (CSF) analysis revealed lymphocytic
pleocytosis with 470 nucleated cells/mm3 (99% of lympho-
cytes) and elevated protein level (84 mg/dl). CSF cultures
and PCR analysis for HSV and VZV were negative.
Electroencephalogram (EEG) disclosed non-specific, slow
activity in the fronto-temporal region. Brain magnetic
resonance imaging (MRI) depicted a few FLAIR hyperin-
tense signals in the white matter. Infectious encephalitis
was first suspected and amoxicillin in conjunction with
aciclovir were administered. Progressive neurologic de-
terioration led to transfer the patient to the intensive
care unit (ICU). On admission, the patient was confused,
agitated, with a Glasgow Coma Score of 12. She also
exhibited facial dyskinesia, ocular deviation with ocular
dipping, and limb dystonia (A video shows this more in
details, see Additional file 1 which shows dyskinesias).
The patient was ventilated. She received rocuronium
bromide (4 mg) and midazolam (10 mg) for intubation
and was maintained on a continuous propofol infusion
(50 to 150 mg/h discontinuously) in order to reach a
Richmond Agitation Sedation Scale between 0 and −3.
Limbic encephalitis was highly suspected because of
her young age, the lack of medical history, the clinical
presentation and the absence of alternative etiology.
* Correspondence: b.francois@unilim.fr
1Intensive Care Unit, University Hospital Dupuytren, Limoges, France
5Service de Réanimation Polyvalente, Centre hospitalier universitaire
Dupuytren, 2, avenue Martin Luther King, 87042 Limoges, Cedex, France
Full list of author information is available at the end of the article
© 2014 Lapébie et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Lapébie et al. BMC Anesthesiology 2014, 14:5
http://www.biomedcentral.com/1471-2253/14/5
Intravenous immunoglobulins (IVIg) were promptly
initiated (0.4 g/kg per day for 5 days). The diagnosis of
anti-NMDA-R encephalitis was confirmed by the pres-
ence of specific antibodies in the CSF, revealed by a
semi-quantitative test cell based assay. Since the patient
exhibited no clinical improvement, high doses of meth-
ylprednisolone were administered intravenously (1 g/day
for 5 days). Body CT scan disclosed a right ovarian tumor
(27 mm) consistent with a teratoma. Tumor resection was
scheduled on Day 19. The patient was then sedated with
propofol 50 mg/h. General anesthesia was induced with
a combination of propofol (100 mg), sufentanil (20 μg)
and atracurium (40 mg) and maintained with sevoflurane
at 2.5% during 70 min. No complication occurred. The
tumor was solid, including teeth and hair and the patho-
logical diagnosis was mature teratoma without malig-
nancy. Sedation after surgery was maintained: propofol
was reintroduced 6 hours after the end of the procedure.
Eight hours after surgery, the patient’s condition deterio-
rated with a marked increase in the frequency and ampli-
tude of dyskinesias (a video shows this in more details;
see Additional file 2 which shows worsened dyskinesias).
Another 8 hours later a tonic-clonic generalized seizure
event occurred. It resolved spontaneously within one
minute. Propofol flow was 50 mg/h; infusion was stopped
because of impaired consciousness. Levetiracetam was
then started. Dyskinesias improved but propofol (50 mg/
h) was reintroduced 14 hours later because of agitation.
Two hours after propofol reintroduction, a second tonic-
clonic generalized seizure event occurred which was
treated with intravenous phenytoin. Propofol was main-
tained (80 mg/h), but dyskinesias increased. Eight hours
after the second seizure propofol was finally stopped as
a side effect was suspected. The neurologic status progres-
sively improved but the patient could not talk. Accord-
ingly, rituximab was administered as a second-line therapy
(375 mg/m2 per week for 4 weeks). The patient was
discharged from ICU on Day 36. At 3-month follow-up,
the patient’s neurological status was slowly improving.
Discussion and conclusions
Anti-NMDA-R encephalitis is identified among auto-
immune limbic encephalitis since 2007 [1,3]. All auto-
immune limbic encephalitis share the same clinical
presentation with psychiatric symptoms (personality
changes, irritability, depression and hallucinations),
short-term memory loss, confusion, coma, seizures
and autonomic instability [1,3]. CSF analysis frequently
identifies a lymphocytic pleocytosis, and EEG typically
depicts delta or theta activity, either diffuse or in
fronto-temporal regions. Brain MRI abnormalities are
less frequent but diffuse hyperintense signal of the
white matter may be encountered, as in the present
case. Anti-NMDA-R encephalitis typically occurs in
young women (mean age, 23 years old). It is characterized
by frequent movement disorders (dystonia and dyskinesia)
and is commonly associated with ovary teratomas (54%
of the cases) [3]. Immunotherapy of anti-NMDA-R en-
cephalitis is initially based on steroids, and subsequently
relies on intravenous immunoglobulin or plasma exchange.
Cyclophosphamide and/or rituximab are second-line
therapies. Early removal of an underlying tumor may
be associated with a good prognosis: up to 80% of pa-
tients fully recover or have mild sequelae after tumor
removal and first-line immunotherapy (corticosteroids
and/or IVIg and/or plasma exchange) [1]. Nevertheless,
the improvement is typically slow, over several months.
The median time from symptom presentation to initial
signs of improvement is 8 weeks (range 2–24 weeks) for
patients with early tumor treatment [3]. Coma, autonomic
instability and dyskinesias improve first, then social be-
havior and executive function [1]. We did not find any
articles reporting a worsening of symptoms following
resection. On the contrary a case of huge improvement
within 48 hours after the operation is reported [4].
Rapid neurological response to tumor removal is how-
ever infrequent; it suggests that anesthetic drugs affect
NMDA-R function [1].
NMDA-R, α-amino-5-methyl-3-hydroxy-4-isoxazole pro-
pionic acid receptor (AMPA-R) and kainate receptor
are the 3 subtypes of ionotropic glutamate receptors.
Anti-NMDA-R antibodies may be produced as a conse-
quence of immunization against ectopic brain tissue
found in teratoma [5] and induce glutamatergic trans-
mission impairment. They bind to the NR1 subunit of
the NMDA-R and disrupt surface cross-talk between
NMDA and Ephrin-B2 receptors. This results in the
displacement of surface GluN2A-NMDA receptors out of
synapses, and leads to a selective and reversible decrease
in NMDA-R surface density at the post-synaptic level of
the glutamatergic synapse which correlates with antibody
titers [6,7]. Inactivation of inhibitory GABAergic inter-
neurons, which express high concentrations of NMDA-R,
has also a key role in pathophysiology [1]. The result is
a hyperglutamatergic state with an imbalance between
NMDA and AMPA pathways [6].
Many anesthetic drugs inhibit NMDA-R and therefore
can induce the same symptoms as those observed in
anti-NMDA-R encephalitis [1]. NMDA-R are strongly
inhibited by nitrous oxide, xenon and ketamine [8]. Al-
though several authors emphasized the threat of potential
worsening of symptoms after the use of these anesthetic
drugs [2,9], no case has yet been reported to the best of
our knowledge.
In our patient, the side effect of general anesthesia is
presumably responsible for the clinical worsening which
followed the teratoma removal. Propofol is a short-acting
drug, administered intravenously, and this phenolic-
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derivative hypnotic agent produces general anesthesia by
enhancing GABAergic transmission [9]. In vitro, propofol
may also block NMDA-R at the concentrations routinely
used to maintain a general anesthesia, by inhibiting the
phosphorylation of NR1 subunit in neurons [10]. An-
other in vitro experiment showed that propofol inhibits
NMDA-R through an allosteric modulation of channel
gating but at higher concentrations than those used in
clinical practice [11]. However, the clinical relevance
of this inhibition is not established. Sevoflurane is an
isopropylether volatile anesthetic which enhances the
GABAergic transmission. Its effect on NMDA pathway
has been demonstrated, with an inhibition of NMDA-gated
currents and NMDA-induced mitochondrial membrane
depolarization [12,13]. Sufentanil and atracurium fail to
affect NMDA-R. Thus we hypothesize that anesthesia
using both propofol and sevoflurane may have facilitated
the inhibition of NMDA pathway, hence worsened the
clinical presentation of anti-NMDA-R encephalitis. Al-
though propofol was also used before surgery in our
patients, its effect on NMDA-R might not have been
sufficient in itself to worsen neurologic symptoms.
Several case series of anti-NMDA-R encephalitis advocate
surgery to remove teratoma, but fail to provide detailed
anesthetic procedure or to describe the postoperative
course. Pascual-Ramirez et al. [2] reported two cases
without any complication of anesthesia (propofol/sevoflur-
ane/fentanyl and propofol/remifentanil, respectively).
Several reasons could explain the difference of results
between these two cases and ours. The dosages of
anesthetic drugs used in the two cases are not reported
and may have been lower than in our case. For the first
patient propofol was not used after the procedure. For
the second patient plasmapheresis was fulfilled before
surgery and could have been more efficient than IVIg
to rapidly decrease anti-NMDA-R titers in serum. Sevo-
flurane was also not used. Kawano et al. [9] reported
another patient with a suspected limbic encephalitis
who underwent a teratoma resection without complication
(remifentanil, thiamylal and sevoflurane) but anti-NMDA-
R level was not determined. Unlike for our patient propofol
was not used. Splinter et al. [14] reported the occurrence
of a rapid and profound hypotension with propofol
used for a diagnostic lumbar puncture performed in a
14-year-old female at the time of diagnosis. Ten months
later, another lumbar puncture was performed under
propofol and sevoflurane without adverse reaction. Dalmau
et al. [1] also reported a pronounced hypotension second-
ary to propofol injection at induction of anesthesia for
a lumbar puncture. The same procedure was performed
several months later with a reduced dose of propofol
and no hypotension was noted that time.
Our observation highlights the specificities of anesthetic
management in patients with anti-NMDA-R encephalitis.
Well-known NMDA antagonists such as nitrous oxide,
xenon, ketamine, tramadol and dextropropoxyphene should
be avoided. Nevertheless, many other drugs that can inhibit
NMDA-R, such as sevoflurane and propofol, could potenti-
ate each other. Accordingly, the inappropriate use of certain
anesthetic drugs must be suspected when the neurological
status worsens after a surgical procedure in patients with
anti-NMDA-R encephalitis. Anesthesia using benzodiaze-
pines, opiates and curares, which fail to interfere with the
NMDA pathway, should be preferred in these patients.
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